Patents by Inventor Christopher S. Schaumburg

Christopher S. Schaumburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclosporin analogs
    Patent number: 10065992
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: September 4, 2018
    Assignee: Allergan, Inc.
    Inventors: Catherine Simone Victoire Frydrych, William Robert Carling, Michael E. Garst, Michael E. Stern, Christopher S. Schaumburg
  • Cyclosporin analogs
    Patent number: 9561259
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: February 7, 2017
    Assignee: Allergan, Inc.
    Inventors: Michael E. Garst, William Robert Carling, David Arthur Scowen, Michael E. Stern, Christopher S Schaumburg
  • CYCLOSPORIN ANALOGS
    Publication number: 20170029469
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 2, 2017
    Inventors: Catherine Simone Victoire Frydrych, William Robert Carling, Michael E. Garst, Michael E. Stern, Christopher S. Schaumburg
  • Cyclosporin analogs
    Patent number: 9493511
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: November 15, 2016
    Assignee: Allergan, Inc.
    Inventors: Catherine Simone Victoire Frydrych, William Robert Carling, Michael E. Garst, Michael E. Stern, Christopher S. Schaumburg
  • Cyclosporin Analogs
    Publication number: 20160022765
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Application
    Filed: October 2, 2015
    Publication date: January 28, 2016
    Inventors: Michael E. Garst, William Robert Carling, David Arthur Scowen, Michael E. Stern, Christopher S. Schaumburg
  • Cyclosporin analogs
    Patent number: 9175042
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Grant
    Filed: October 11, 2011
    Date of Patent: November 3, 2015
    Assignee: Allergan, Inc.
    Inventors: Michael E. Garst, William Carling, David Scowen, Michael E. Stern, Christopher S. Schaumburg
  • CYCLOSPORIN ANALOGS
    Publication number: 20150065433
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Application
    Filed: November 6, 2014
    Publication date: March 5, 2015
    Applicant: ALLERGAN, INC.
    Inventors: Catherine Simone Victoire Frydrych, William Robert Carling, Michael E. Garst, Michael E. Stern, Christopher S. Schaumburg
  • KLK-13 antibody inhibitor for treating dry eye
    Patent number: 8821874
    Abstract: Disclosed herein is a method of treating dry eye with a KLK-13 antibody.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: September 2, 2014
    Assignee: Allergan, Inc.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Jianping Gao
  • KLK-13 ANTIBODY INHIBITOR FOR TREATING DRY EYE
    Publication number: 20140017245
    Abstract: Disclosed herein is a method of treating dry eye with a KLK-13 antibody.
    Type: Application
    Filed: July 22, 2013
    Publication date: January 16, 2014
    Applicant: Allergan, Inc.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Jianping Gao
  • METHODS OF TREATING OCULAR AND OTHER DISEASES WITH SYN-134R POLYPEPTIDE
    Publication number: 20130323202
    Abstract: Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides.
    Type: Application
    Filed: July 22, 2013
    Publication date: December 5, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Larry A. Wheeler
  • Methods of treating ocular and other diseases with Syn-134R polypeptide
    Patent number: 8491912
    Abstract: Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: July 23, 2013
    Assignee: Allergan, Inc.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Larry A. Wheeler
  • Cyclosporin Analogs
    Publication number: 20120135939
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Application
    Filed: October 11, 2011
    Publication date: May 31, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Michael E. Garst, William Robert Carling, David Arthur Scowen, Michael E. Stern, Christopher S. Schaumburg
  • Cyclosporin Analogs
    Publication number: 20120088734
    Abstract: Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions.
    Type: Application
    Filed: October 11, 2011
    Publication date: April 12, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Catherine Simone Victoire Frydrych, William Robert Carling, Michael E. Garst, Michael E. Stern, Christopher S. Schaumburg
  • IL-10 AND METHODS OF TREATING OCULAR AND OTHER DISEASES
    Publication number: 20110318303
    Abstract: Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides.
    Type: Application
    Filed: June 16, 2011
    Publication date: December 29, 2011
    Applicant: Allergan, Inc.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Larry A. Wheeler
  • IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
    Publication number: 20110311527
    Abstract: Disclosed herein is a method of treating certain ocular and other diseases with an anti-IL-23p19 antibody.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 22, 2011
    Inventors: Michael E. Stern, Christopher S. Schaumburg
  • TGF-ß AND METHODS OF TREATING OCULAR AND OTHER DISEASES
    Publication number: 20110312886
    Abstract: Disclosed herein is a method of treating ocular and systemic conditions by administering a TGF-?.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 22, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Michael E. Stern, Christopher S. Schaumburg, Karyn F. Siemasko, Larry A. Wheeler